Table 2.

Effect of the MAMMS screening program on incidence of wasting and days to diagnosis and malnutrition treatment coverage.

	Primary outcomea					Secondary outcome
	N	Child-years	Events	Incidence rate per 100 child-years (95% CI)	Median days to wasting diagnosis (IQR)	Missed cases	Treatment coverage at 6-months	Mean duration of treatment in weeks (95% CI)b	Treatment successc
SOC	601	265.4	54	19.8 (15.0, 24.6)d	58 (22, 94)	8 (13.1%)	55.6%	9.14 (8.8–9.5)e	50 (86.2%)
MAMMS	599	271.4	37	13.4 (9.3, 17.4)d	63 (23, 92)	2 (5.1%)	83.3%	8.8 (8.4–9.2)e	35 (92.1%)

Abbreviations: CI, confidence interval; IQR, interquartile range; MAMMS, Maternally Administered Malnutrition Monitoring System; SOC, standard of care.

^aIncludes only cases identified by the SOC or MAMMS screening programs prior to the 6-month follow-up visit.

^bIncludes all children identified with wasting, including those identified at the 6-month follow-up visit, and those who initiated malnutrition treatment.

^cTreatment success was defined as recovery from wasting (MUAC ≥12.5 cm) among those who started malnutrition treatment, i.e., excluding the caregivers of three children in the SOC group and one in the MAMMS group that chose not to start treatment for wasting.

^dp-value = 0.063 for a difference in the incidence of wasting detected by the MAMMS versus SOC programs.

^ep-value = 0.712 for a difference in the mean duration of treatment between MAMMS and SOC groups.